Cost of Illness, Quality of Life, and Work Outcomes in Active Ankylosing Spondylitis Patients Treated With Adalimumab in China

Cost of Illness, Quality of Life, and Work Outcomes in Active Ankylosing Spondylitis Patients Treated With Adalimumab in China

Objectives: To access the cost of illness, quality of life and work limitation in active ankylosing spondylitis (AS) patients using adalimumab in China.Methods: A prospective study was performed in 91 patients with active AS in China. Adult patients (aged ≥ 18 years) fulfilled the 1984 New York modi...

Full description

Bibliographic Details
Main Authors: Liudan Tu, Ya Xie, Zetao Liao, Yutong Jiang, Qing Lv, Shuangyan Cao, Qiujing Wei, Jieruo Gu
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Public Health
Subjects:
ankylosing spondylitis
work outcomes
cost of illness
quality of life
adalimumab
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2020.602334/full

Internet

https://www.frontiersin.org/articles/10.3389/fpubh.2020.602334/full

Similar Items